NCT06656390 2026-03-06
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 1/2 Recruiting
Clinical Trials
163 trialsNCT07105033 2026-03-02
Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT07009886 2026-02-19
Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT07408310 2026-02-13
Trial of Spiritual Care Interventions for Patients With Cancer
Weill Medical College of Cornell University
Phase NA Not yet recruiting
NCT07133269 2026-02-12
Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients
Singapore General Hospital
Phase NA Recruiting
NCT05408507 2026-02-09
Care Planning Framework in Advanced Cancer (ABC123)
University of Colorado, Denver
Phase NA Active not recruiting
NCT05605509 2026-02-06
RP-6306 in Patients With Advanced Cancer
Canadian Cancer Trials Group
Phase 2 Completed
NCT07393529 2026-02-06
SONATA 2
University of Rochester
Phase NA Not yet recruiting
NCT07269145 2026-01-28
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Recruiting
NCT03994601 2026-01-20
An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers
Bristol-Myers Squibb
Phase 1/2 Completed
NCT04590885 2026-01-20
CCST2
Duke University
Phase NA Completed
NCT01087554 2026-01-16
Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT04495296 2025-12-19
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors
Suzhou Transcenta Therapeutics Co., Ltd.
Phase 1/2 Recruiting
NCT07291050 2025-12-18
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Not yet recruiting
NCT06662760 2025-11-25
Clinical Trial of TQB3002 in Patients With Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Recruiting
NCT02743494 2025-11-18
CheckMate 577
Bristol-Myers Squibb
Phase 3 Completed
NCT05025085 2025-10-15
A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors
Agenus Inc.
Phase 1 Completed
NCT03446040 2025-09-18
An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread
Bristol-Myers Squibb
Phase 1/2 Terminated
NCT03900442 2025-09-02
Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort
Prescient Therapeutics, Ltd.
Phase 1 Completed
NCT06092580 2025-09-02
Phase 1 Study of AWT020 in Advanced Cancer
Anwita Biosciences
Phase 1 Recruiting
NCT04467593 2025-08-05
MATTERS
ElmediX
Phase NA Completed
NCT05735496 2025-08-01
Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Active not recruiting
NCT04757155 2025-07-17
iCALM
University Health Network, Toronto
Phase NA Active not recruiting
NCT06963814 2025-07-17
Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors
HC Biopharma Inc.
Phase 1 Recruiting
NCT04936568 2025-07-08
PCRSS
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase NA Completed
NCT04435444 2025-07-03
Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT05276310 2025-06-27
A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy
ImmuneOncia Therapeutics Inc.
Phase 1 Recruiting
NCT06811376 2025-04-27
Pilot Trial of Spiritual Care Interventions for Patients With Cancer
Weill Medical College of Cornell University
Phase NA Recruiting
NCT06616298 2025-04-15
ALIGN
University of Colorado, Denver
Phase NA Recruiting
NCT03459222 2025-04-02
An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread
Bristol-Myers Squibb
Phase 1/2 Completed
NCT06707610 2025-03-12
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors
Shanghai Allink Biotherapeutics Co., Ltd.
Phase 1 Recruiting
NCT05113199 2025-03-03
Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer
Mayo Clinic
Phase NA Completed
NCT03352531 2025-02-28
Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors
Akeso
Phase 1 Completed
NCT05315427 2025-02-14
MSPD
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Completed
NCT04149704 2025-01-20
Videos for Advance Care Planning in Young Adults
Dana-Farber Cancer Institute
Phase NA Completed
NCT03408314 2024-11-29
The PediQUEST Response Intervention Study
Massachusetts General Hospital
Phase NA Completed
NCT04270864 2024-10-18
PRIMO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Terminated
NCT02193633 2024-09-26
TAX-TORC
Royal Marsden NHS Foundation Trust
Phase 1 Completed
NCT02338622 2024-09-26
ComPAKT
Royal Marsden NHS Foundation Trust
Phase 1 Completed
NCT02944864 2024-09-23
A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Terminated
NCT01394016 2024-09-19
A Phase 1 Study of LY2835219 In Participants With Advanced Cancer
Eli Lilly and Company
Phase 1 Completed
NCT03763032 2024-09-19
Psychosocial Intervention in Latino Patients with Advanced Cancer
University of Colorado, Denver
Phase NA Completed
NCT04335253 2024-09-19
First-In-Human Study of EOS884448 in Participants with Advanced Cancers.
iTeos Therapeutics
Phase 1 Completed
NCT03122249 2024-05-08
OASIS
University of Iowa
Phase NA Withdrawn
NCT06338683 2024-03-29
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer
Qinghai Red Cross Hospital
Phase 3 Recruiting
NCT05128539 2024-03-26
A Study Explore JS001+JS002 in Patients With Advanced Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Terminated
NCT05894421 2024-03-12
TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Recruiting
NCT05154630 2024-01-18
Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Terminated
NCT01954316 2024-01-17
A Study of CFI-400945 Fumarate in Patients With Advanced Cancer
University Health Network, Toronto
Phase 1 Completed
NCT04480008 2024-01-16
Resilient Living Program for Patients With Advanced Cancer and Their Caregivers
Mayo Clinic
Phase NA Completed